In various autoimmune diseases such as multiple sclerosis, sarcoidosis, Crohn’s disease, and RA, IFNγ-producing Th17.1 cells are enriched at the site of inflammation and are thought to be especially pathogenic and drug resistant [9, 11, 14, 27, 28]. This evidence concerns the gene IFNG and Crohn disease.